EuroAPI falls by 8% on the back of unfavorable comments from Deutsche Bank, which reaffirms its 'sell' recommendation on EuroAPI with a price target lowered from three to 2.50 euros, commenting on the healthcare group's announcements on Wednesday evening.

While the company has reached a non-dilutive agreement for financing from Sanofi, the broker notes that EuroAPI has not provided any explicit medium-term sales or margin projections, which it considers a disappointment.

Copyright (c) 2024 CercleFinance.com. All rights reserved.